Starsource Multitrade Ltd Board of Directors
Board of Directors at Starsource Multitrade Ltd
Executive Director & CFO
Director & Chief Executive Off
Independent Director
Independent Director
Non Executive Director
Key Highlights
- Ruchit Mehta joins the board as Managing Director & CEO, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Utsav Trivedi joins the board as Executive Director & CFO, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Shilpy Chopra joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Sarvagya Goel joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Simiran Tripathi joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Starsource Multitrade Ltd
NSE: STARSOURCE
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 30 Mar 2026 | 111.23 |
| 27 Mar 2026 | 105.97 |
| 25 Mar 2026 | 100.93 |
| 24 Mar 2026 | 96.13 |
| 23 Mar 2026 | 91.56 |
| 20 Mar 2026 | 87.2 |
| 19 Mar 2026 | 83.05 |
| 18 Mar 2026 | 86.81 |
| 17 Mar 2026 | 82.68 |
| 16 Mar 2026 | 78.75 |
Company Fundamentals for Starsource Multitrade Ltd
Market Cap
15 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
11.1
Day’s High
111.26
Day’s Low
108.5
DTE
0.0
ROE
-850.1
52 Week High
152.9
52 Week Low
75.0
ROCE
-830.6
Market Price of Starsource Multitrade Ltd
1M
1Y
3Y
5Y
Starsource Multitrade Ltd News Hub
Chemo Pharma Laboratories to announce Quarterly Result
Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 28 October
Read more
17 Oct 24
Chemo Pharma Laboratories standalone net profit rises 38.64% in the September 2024 quarter
Net profit of Chemo Pharma Laboratories rose 38.64% to Rs 0.61 crore in the quarter ended September
Read more
29 Oct 24
Chemo Pharma Laboratories reports standalone net loss of Rs 0.17 crore in the December 2024 quarter
Net loss of Chemo Pharma Laboratories reported to Rs 0.17 crore in the quarter ended December 2024 a
Read more
27 Jan 25
Chemo Pharma Laboratories to table results
Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 27 January
Read more
15 Jan 25
